Live news related to PHARMING GROUP stock (NL0010391025): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on PHARMING GROUP mainly cover earnings publications, M&A activity et analyst notes. The stock trades at €1,10 on Euronext Paris, down 1,44% at the last update. This page lists the articles published on PHARMING GROUP stock to track the share price, company announcements and any item likely to influence market perception.
Pharming Group announced on Thursday that the FDA has accepted its supplemental New Drug Application (sNDA) for Joenja (leniolisib) to treat children …
CEO Fabrice Chouraqui will engage in a Fireside Chat session on Thursday, June 4.
The European Commission granted marketing authorization on Friday for Joenja (leniolisib), the first and only approved treatment in the European Union…
Pharming Group announced on Thursday a series of presentations at the annual congress of the Clinical Immunology Society (CIS), taking place from May …
Pharming Group announced its first quarter 2026 results on Thursday, showing an 8% decrease in total revenue to $72.4 million from $79.1 million a yea…
Pharming Group announced on Friday, March 27, 2026, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (E…
Pharming Group announces the approval by the Japanese Ministry of Health, Labour and Welfare of Joenja® (leniolisib), a selective inhibitor of phospho…
Pharming Group reports strong 2025 results with a 27% increase in revenue and a shift to operational profitability, marking a strategic turning point …
Pharming Group N.V. announces that it will present its unaudited preliminary financial results for the fourth quarter and the full year of 2025 on Thu…
Pharming Group N.V. announces its participation in the 36th annual Oppenheimer Healthcare Life Sciences Conference, which will be held virtually on Fe…
